Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-04-08 16:32:44 ET · period of report 2026-04-07 · accession 0001960048-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-08 16:32 | 2026-04-07 | PCVX | Cowan Elvia | SVP, CAO, Fin | M - OptEx | $25.92 | +3,000 | 32.0K | +10% | +$77.8K |
| DT | 2026-04-08 16:32 | 2026-04-07 | PCVX | Cowan Elvia | SVP, CAO, Fin | S - Sale+OE | $60.00 | -3,000 | 29.0K | -9% | -$180.0K |
| DT | 2026-04-08 16:32 | 2026-04-07 | PCVX | Cowan Elvia | SVP, CAO, Fin | M - OptEx | $0.00 | -3,000 | 93.1K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-07 | M | A | 3,000 | $25.92 | 31,975 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-07 | S | D | 3,000 | $60.00 | 28,975 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. |
| 3 | Derivative | Stock Option (right to buy) | 2026-04-07 | M | D | 3,000 | $0.00 | 93,068 | D | $25.92 · — to 2032-08-08 | 3,000 Common Stock | (F2) 1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |